FIGURE

Fig. 3

ID

ZDB-FIG-181207-56

Publication

Jin et al., 2018 - Comparison of efficacy and toxicity of bevacizumab, endostar and apatinib in transgenic and human lung cancer xenograft zebrafish model

Other Figures

All Figure Page

Back to All Figure Page

Fig. 3

Antitumor activity of anti-angiogenesis alone and in combination with pemetrexed. On 2dpf, CM-Dil labeled A549 xenograft zebrafish embryos were treated with three anti-angiogenesis alone and in combination with pemetrexed for 3 days. Pemetrexed (P) (2 ng per embryo), bevacizumab (B) (28 ng per embryo) and endostar (E) (11 ng per embryo) were injected into embryos and apatinib (A) (0.5 μg/mL) was dissolved in breeding water. (A) Fluorescent images showing A549 xenograft zebrafish larvae at 5dpf treated with different inhibitors. (B) Quantification of fluorescence intensity of tumor. (C) Tumor growth inhibition rates were calculated according to the fluorescence intensities of tumor. Each bar represents the mean ± SEM. One-way ANOVA followed by Dunnett’s test, *p < 0.05, **p < 0.01, ***p < 0.001 when compared with control group.

Expression Data

Expression Detail

Antibody Labeling

Phenotype Data

Phenotype Detail

Acknowledgments

This image is the copyrighted work of the attributed author or publisher, and ZFIN has permission only to display this image to its users. Additional permissions should be obtained from the applicable author or publisher of the image. Full text @ Sci. Rep.